Evaluating the Cardiovascular Safety of Naltrexone/Bupropion in the United States

被引：0
|
作者：
Burns, Dustin [1 ]
Kyle, Michael L. [2 ]
Murray, Catherine Rogers [1 ]
Watson, Heather [1 ]
Swaney, Jeff R. [1 ]
Spevack, Samuel [3 ]
Leonhard, Megan [1 ]
Simon, Michael A. [1 ]
Moynihan, Emma
Lapane, Kate L. [4 ]
Wang, Shirley V. [5 ]
Longo, Craig [6 ]
Ritchey, Mary E. [7 ]
Dore, David [1 ]
机构：
[1] Exponent Inc, Menlo Pk, CA USA
[2] Currax Pharmaceut, Brentwood, Essex, England
[3] Exponent, Menlo Pk, CA USA
[4] Consultant Exponent, Menlo Pk, CA USA
[5] Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Boston, MA USA
[6] APHMFP, Providence, RI USA
[7] CERobs Consulting LLC, Chapel Hill, NC USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
540
引用
收藏
页码：224 / 224
页数：1
相关论文
共 50 条
  • [21] Safety and efficacy of bupropion for smokers hospitalized with acute cardiovascular disease
    Rigotti, NA
    Thorndike, AN
    Regan, S
    Pasternak, RC
    Chang, Y
    McKool, K
    Emmons, K
    Singer, DE
    Swartz, S
    Torres-Finnerty, N
    NICOTINE & TOBACCO RESEARCH, 2005, 7 (04) : 682 - 682
  • [22] Naltrexone and bupropion reduce the prevalence of the metabolic syndrome
    Greenway, Frank L.
    Erickson, Janelle
    Duna-Yevich, Eduardo
    Tollefson, Gary
    DIABETES, 2008, 57 : A738 - A738
  • [23] Characterization of the Effect of Naltrexone/Bupropion on Body Composition
    Tsoukas, Michael
    Tardio, Vanessa
    Fils-Aime, Nadege
    Burrows, Melonie
    Blavignac, Jessica
    Camacho, Fernando
    Gould, Errol
    Barakat, Maxime
    OBESITY, 2020, 28 : 66 - 66
  • [24] ANALYSIS OF COMBINATION OF NALTREXONE WITH BUPROPION FOR WEIGHT LOSS
    Pirzada, Hannah
    Anwar, Saeed
    ul Hasan, Nadeem
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (10): : 10275 - 10278
  • [25] Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia?
    El Hayek, Samer A.
    Shatila, Malek A.
    Adnan, Jana A.
    Geagea, Luna E.
    Kobeissy, Firas
    Talih, Farid R.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2022, 22 (09) : 737 - 749
  • [26] Naltrexone/bupropion increases risk of serious AEs
    Reactions Weekly, 2020, 1788 (1) : 8 - 8
  • [27] Characterization of the effect of naltrexone/bupropion on body composition
    Tardio, Vanessa
    Yin, Peter
    Camacho, Fernando
    Barakat, Maxime
    Tsoukas, Michael A.
    DIABETES OBESITY & METABOLISM, 2025, 27 (05): : 2397 - 2404
  • [28] Contrave - A Combination of Bupropion and Naltrexone for Weight Loss
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1455): : 112 - 114
  • [29] Naltrexone/bupropion could affect ability to drive
    Reactions Weekly, 2019, 1768 (1) : 4 - 4
  • [30] Role of Bupropion Plus Naltrexone for the Management of Obesity
    Booth, Kemper
    Clements, Jennifer N.
    JOURNAL OF PHARMACY TECHNOLOGY, 2016, 32 (03) : 125 - 132
12345